Clinical Trial Update: Haploidentical CD34+ Selected Cells Combined With Single Unit Umbilical Cord Blood Transplant for Treatment of High-risk Hematologic Disorders [NA]

View source ↗

Summary

A completed clinical trial investigating haploidentical CD34+ selected cells combined with a single-unit umbilical cord blood transplant for high-risk hematolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Disorders

Drugs mentioned

• Haploidentical CD34+ selected cells combined with single-unit umbilical cord blood transplant

Snippet

Sponsor: University of Colorado, Denver | Conditions: Hematologic Disorders | NA | Status: COMPLETED | Results posted: 2025-08-15